Ifora Ifora

Ifora Ifora

Auto-generated profile, based on publicly available information

Ifora Ifora

Department of Pharmacology and Clinical Pharmacy, School of Pharmaceutical Sciences Padang (STIFARM Padang), West Sumatera, Indonesia, 25147

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2022 in Journal of Drug Delivery and Therapeutics
Verified
Journal Article
Open access
PDF file
SOSri Niza Oktavia
Sri Niza Oktavia
IIIfora Ifora
Ifora Ifora
FFFitra Fauziah
Fitra Fauziah
Inflammation is a protective response to injury or tissue damage and acts by eliminating harmful stimuli such as pathogens cell damage and initiates the healing process. Azadirachta indica was known as medicinal plant with various pharmacological activities. This review aims to summarize the scientific activity of A.indica as an anti-inflammatory, analgesic, and antipyretic with experimental models either in vivo or in vitro taken from several databases such as Google Scholar, ScienceDirect, and PubMed over the last ten years (2011- 2021). From the data, A.indica was proven to be anti-inflammatory by inhibiting pro-inflammatory cytokines such as IL-6, NFkB, COX2, IL-1, IL-6, TNF-α, IFN- γ, and reducing the volume of edema. Potential analgesic indicated by decreasing stomach writhing and reducing pain sensation in rats. The antipyretic activity was characterized by a decrease in rats' body temperature. This review proves that natural products from A.indica have anti-inflammatory, analgesic, and antipyretic potential. Keywords: Analgesic, Azadirachta, Fever, Inflammation, Neem

15 May 2022 in Journal of Drug Delivery and Therapeutics
Verified
Journal Article
Open access
PDF file
MRMuhanifa Rustam
Muhanifa Rustam
IIIfora Ifora
Ifora Ifora
FFFitra Fauziah
Fitra Fauziah
Background: Inflammation is a natural reaction that the body has when exposed to physical damage. Inflammation in numerous organs implies atherosclerosis, diabetes, dermatitis, arthritis, obesity, and cancer. The review's objective was to summarize the currently known eriocitrin's anti-inflammatory effects. Methods: A review was conducted on a study of the anti-inflammatory effects of eriocitrin conducted from January 2010 to April 2021. Results: Based on eligibility criteria, six studies were included in this study consisting of in vitro and in vivo studies. Some pharmacological studies have suggested that eriocitrin has the potential to treat diseases involving inflammatory responses. Nitric Oxide (NO), IL-1β, IL-6, IL-8, TNF-α, NF-κB, MPO, MAPK, and MMP-9 secretion were reduced by eriocitrin, inhibiting cell apoptosis, and the production of pro-inflammatory cytokines, but increases the content of IL-10, Nrf2, DUSP14, HO-1, and NQ01. Conclusions: Eriocitrin has been shown to have anti-inflammatory effects in both in vitro and in vivo studies. Keywords: eriocitrin; flavonoids; inflammation

15 February 2025 in Journal of Drug Delivery and Therapeutics
Verified
Journal Article
Open access
PDF file
IIIfora Ifora
Ifora Ifora
DHDachriyanus Hamidi
Dachriyanus Hamidi
MSMeri Susanti
Meri Susanti
FWFatma Sri Wahyuni
Fatma Sri Wahyuni
Objective: Breast cancer metastasis is a major cause of mortality, highlighting the need for effective anti-migratory therapies. This study investigated the synergistic anti-migratory effects of Garcinia cowa bark ethanol extract and doxorubicin on T47D breast cancer cells, aiming to explore its potential as a combination therapy to inhibit cancer cell migration Methods: T47D cells were treated with Garcinia cowa bark ethanol extract (GCBEE) (130 µg/mL), doxorubicin (Dox) (0.026 µg/mL), and their combination. Cell migration was evaluated using the scratch assay, with scratch closure monitored at 0, 24, and 48 hours. Results: The combination of GCBEE (130 µg/mL) and Dox (0.026 µg/mL) significantly inhibited T47D cell migration at both 24 and 48 hours, compared to the individual treatments of DOx (0.026 µg/mL) alone and GCBEE (130 µg/mL) alone. Conclusions: The combination of Garcinia cowa ehtanol extract and doxorubicin demonstrates synergistic anti-migratory effects on T47D breast cancer cells, suggesting its potential as an adjuvant therapy to enhance the efficacy of doxorubicin in preventing metastasis. Keywords: Garcinia cowa, doxorubicin, T47D cells, anti-migration, scratch assay, combination therapy.

7 November 2025 in International Journal of Applied Pharmaceutics
Verified
Journal Article
Open access
PDF file
IIIfora Ifora
Ifora Ifora
DHDachriyanus Hamidi
Dachriyanus Hamidi
MSMeri Susanti
Meri Susanti
FWFatma S. Wahyuni
Fatma S. Wahyuni
Objective: To evaluate the effects of ethanol extract of Garcinia cowa bark (EEGCB) and doxorubicin (Dox), both individually and in combination, on cell cycle regulation and protein expression in T47D breast cancer cells. Methods: T47D cells were treated with EEGCB (130 µg/ml), Dox (0.026 µg/ml), and a combination of both, and flow cytometry was used to analyze cell cycle distribution and the expression of p53, Cyclin D, and Cyclin E. Results: EEGCB induced apoptosis in T47D cells, increasing the subG1 population (p<0.0001), while Dox caused G2/M arrest (p<0.0001). Combined treatment enhanced both effects. EEGCB upregulated cyclin D/E, yet the combination reduced their expression, suggesting altered cell cycle regulation. Critically, EEGCB alone or with Dox significantly elevated p53 levels (44.6±0.592% and 37.6±1.662%, respectively; p<0.0001), implicating p53 in its anticancer activity. These results demonstrate EEGCB’s dual pro-apoptotic and cell cycle-disrupting effects, with potential chemosensitizing properties. Conclusion: These findings highlight EEGCB as a potential adjunct to conventional chemotherapy, providing a scientific basis for further exploration in breast cancer therapy.